can semaglutide cause kidney problems In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist was effective in preventing progression of disease in patients with type 2 diabetes and chronic kidney disease Renal effects of GLP-1 receptor
Description
Wegovy might be preferred if: You want significantly greater weight loss

Any substantial weight loss can include both fat mass and lean mass

Despite this mild increase in heart rate, large-scale cardiovascular outcome trials have consistently demonstrated robust major adverse cardiovascular event (MACE) reductions, indicating that this mild tachycardia does not translate to increased cardiovascular risk for most subjects

Since patients in the study population with obesity were for the first time prescribed semaglutide after 6/2021, there was no overlap in the exposure cohorts for these two study populations
:max_bytes(150000):strip_icc()/VWH-GettyImages-2178836417-ee318a41780b44e9af3ff47de83fafd7.jpg)
Funding The author(s) declare that financial support was received for the research, authorship, and/or publication of this article

It has been shown to have powerful effects on many different biological systems